All Type of News
Drug re-classification plan hit snag
Early in June, the Korea Food and Drug Administration decided to switch a total of 273 over-the-counter drugs to prescription drugs and 212 prescription items to OTC drugs. After consulting with social leaders, the dr...
Government says plan will protect public health
In response to the latest wrangling between the government and the Korean Medical Association erupted on internet, the National Health Insurance Corporation refuted the KMA’s advertisement carried in a daily paper on ...
Binex buys 22% stake in Aprogen
Binex Co. has bought a 22 percent stake in Aprogen from Schnell Biopharmaceuticals for 16 billion won to take lead in biosimilars, industry sources said Wednesday.
Biosimilars, or imitation biopharmaceuticals, are ...
Antipyretics, analgesics and anti-inflammatory agents most favored by pharmacy visitors at nighttime
Antipyretics, analgesics and anti-inflammatory agents are drugs in Jeju Island favored by customers and sightseeing visitors who make their visit to pharmacies at 10 to 12 o’clock in the evening, a local pharmacists a...
4 pharmaceutical wholesalers go bankrupt
Four domestic drug wholesalers have been declared bankrupt over the recent 15 days after failing to honor their commercial papers.
The bankruptcies of these wholesalers, suffering from cash flow problems, were main...
Zytiga approved for metastatic prostate cancer
Janssen Korea said Tuesday that the Korea Food and Drug Administration has approved Zytiga (abiraterone acetate), an oral, once-daily medication for use in combination with prednisone for the treatment of men with met...
Patients call for insurance coverage of Celgene’s multiple myeloma drug
Will multip myeloma patients be able to get cheaper and better drugs this year? Now all eyes are on the government’s decision on the health insurance coverage of Revlimid (lenalidomide), a new drug for multiple myelom...
Pharmaceutical firms vie for new drugs
Korean companies’ zeal toward new drug development is expected to bear fruits as the government has since 2004 backed the pharmaceutical industry as a key growth engine of the next decade, according to the Korean Drug...
230,000 people to benefit from medical fee refunds
From July 13, a total of 221.3 billion won will be refunded to 230,000 people who paid medical expenses of over 2 million won to 4 million won last year, according to health authorities.
The measure is aimed at les...
KFDA discloses 17 state-release drugs
Korea’s 17 state-release medicines were made public on Tuesday in a website of the Korea Food and Drug Administration.
These drugs include a variety of vaccines produced by Green Gross Corp., GlaxoSmithKline, MSD K...
